Pharma Journalist -

Takeda Pharmaceutical Company Limited and BioSurfaces, Inc. announced today that they have entered into an agreement to initiate a research program designed to develop innovative…
Read More...

Brainstorm Cell Therapeutics announced that the California Institute for Regenerative Medicine (CIRM) has awarded Brainstorm a grant of $16 million to support the pivotal Phase 3 study…
Read More...

Takeda Pharmaceutical Company Limited and Schrödinger announced the formation of a multi-target research collaboration directed to diseases that align with Takeda’s core therapeutic…
Read More...

Boehringer Ingelheim announced a $217 million investment to upgrade and expand their Fremont manufacturing facility. This investment will bring nearly 300 new high-wage and…
Read More...

STA Pharmaceutical Co., Ltd. – a WuXi AppTec subsidiary and the leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing –…
Read More...

BioLight Life Sciences announced successful results from its glaucoma insert VS101 ("Eye-D latanoprost insert") Phase 1/2a clinical trial, which demonstrated its ability to lower…
Read More...

Medidata announced that BeiGene, a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, will expand…
Read More...

Pfizer Inc. and Basilea Pharmaceutica announced that they have completed the licensing agreement whereby Pfizer has obtained the exclusive commercialization rights in Europe to CRESEMBA…
Read More...

Oncology Venture AB and Novartis Pharma AG (Basel, Switzerland) have entered into an agreement providing Oncology Venture with an option right to  execute an exclusive license to…
Read More...

ModGene Pharma announced the issuance of US Patent 9,707,231, entitled "Compositions and Methods for Reduction of Amyloid-beta Load." The claims cover the use of an imatinib-related…
Read More...